Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies
- 18 August 2020
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (1) , 211-214
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemiaBlood, 2019
- Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromesBlood, 2018
- Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and ControversiesCurrent Hematologic Malignancy Reports, 2018
- Clinical Implications of Clonal HematopoiesisMayo Clinic Proceedings, 2018
- Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignanciesBlood Advances, 2018
- Genomics of Acute Myeloid Leukemia Diagnosis and PathwaysJournal of Clinical Oncology, 2017
- Inherited DDX41 mutations: 11 genes and countingBlood, 2016
- Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignanciesBlood, 2016
- Inherited and Somatic Defects in DDX41 in Myeloid NeoplasmsCancer Cell, 2015
- ANKRD26-related thrombocytopenia and myeloid malignanciesBlood, 2013